BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:California Life Sciences
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260922T120000
DTEND;TZID=America/Los_Angeles:20260922T130000
DTSTAMP:20260831T160907Z
CREATED:20260831T160531Z
LAST-MODIFIED:20260831T160907Z
UID:10001181-1790078400-1790082000@www.califesciences.org
SUMMARY:State of the Venture Capital Financing Market - Day 1
DESCRIPTION:Paul Hastings LLP is hosting a 2-day series at MBC BioLabs on September 22\, 2026 (1030 Brittan Ave\, San Carlos) and September 23\, 2026 (135 Mississippi St\, SF). \nPlease join us for a discussion of the current state of the venture capital market financing and a Q&A session with VCs from the Bay Area life sciences community. \nModerator: James Huie\, Paul Hastings LLP \nSpeakers: \nColin Walsh\, PhD\, Goldman Sachs Alternatives\nColin Walsh\, PhD is a Managing Director and Senior Investor on the Life Sciences Investing team within Goldman Sachs Alternatives. Prior to joining the firm\, Colin was a Partner at Qiming Venture Partners USA. He has more than ten years of experience working as an investor and operator in early-stage life sciences companies. Colin earned dual BS degrees in Chemical Engineering and Biochemistry from the University of Massachusetts\, Amherst\, and a PhD from the UC Berkeley-UCSF Graduate Program in Bioengineering. \nZach Collins\, PhD\, MBC Capital\nZach Collins\, PhD is a Partner in Mission BioCapital’s San Francisco office. He focuses on investments in early-stage biopharmaceutical companies and launching early-stage company operations in collaboration with entrepreneurs at times through interim executive roles. He holds board roles at Cavalry Biosciences\, Nuvig Therapeutics\, Jupiter Bioventures\, and additional early-stage portfolio companies. Zach served on the board of SiteOne Therapeutics through its 2025 acquisition by Eli Lilly for up to $1B. At MBC Biolabs\, Zach supports startups as an Entrepreneur Success Partner. His training is in molecular biology & genetics. While at Harvard Medical School\, Zach co-authored work that was recognized by Science as 2018’s Breakthrough of the Year. Zach holds a Ph.D. in Biological and Biomedical Sciences from Harvard University and a B.S. in Biology from George Washington University. \nAlexis Ji\, Primer Ventures\nDr. Alexis Ji is the Founding Partner of Primer Ventures\, leveraging her two decades of expertise in research and investment in the biopharmaceutical and genomics industries. Primer Ventures is a venture capital firm investing in early-stage companies in the fields of life science tools and diagnostics\, innovative therapeutics\, and digital health. It provides early capital to empower visionary entrepreneurs in translating cutting-edge science and technologies into transformative products. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/state-of-the-venture-capital-financing-market-day-1/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260916T110000
DTEND;TZID=America/Los_Angeles:20260916T140000
DTSTAMP:20260827T204920Z
CREATED:20260827T204920Z
LAST-MODIFIED:20260827T204920Z
UID:10001175-1789556400-1789567200@www.califesciences.org
SUMMARY:MBC BioLabs Fall Life Science Vendor’s Showcase
DESCRIPTION:Join us for our Fall Life Science Vendor Showcase\, bringing together innovative scientific and business solutions tailored for early-stage biotech teams. Meet industry experts\, explore new technologies\, and discover tools that can accelerate your work at MBC BioLabs. \n🍁 What to Expect\nDiscover Solutions for Startups\nExplore tools and services designed to support drug discovery\, molecular biology\, genomics\, instrumentation\, operational efficiency\, and company growth. \nLunch Included\nPick up your lunch ticket at check-in and enjoy a meal while you explore the showcase. \nMeet New Partners & Build Your Network\nConnect with leading vendors who offer cutting-edge technologies and services to strengthen your R&D pipeline. \n👥 Who Should Attend\nThis showcase is ideal for: \n\nFounders and early-stage biotech teams\nResearch associates and bench scientists\nPlatform\, screening\, and discovery scientists\nOperations\, lab managers\, and procurement teams\nAnyone looking to evaluate new tools\, technologies\, or service providers that support R&D and company growth\n\n🚗 Parking Information\nPlease note that there is limited parking available at 1030 Brittan Ave. Limited street parking may be available in the surrounding neighborhood. We strongly encourage attendees to plan ahead and consider public transit or rideshare options for an easier arrival. \n🧪 Participating Vendors\n\nAgilent Technologies\nBiocom\nBionova Scientific\nBioIVT\nChemPartner\nClutch Biotechnologies\nEurofins Viracor BioPharma\nKACTUS\nKaironexus Innovations Inc.\nNovogene Corporation Inc.\nRevvity\nScience Exchange (HappiLabs)\nSignios\nSino Biological\nSony Biotechnology Inc.\nSynfini\, Inc.\nTargetMol Chemicals\nTecan\nVazyme Biotech\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/mbc-biolabs-fall-life-science-vendors-showcase/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260914T090000
DTEND;TZID=America/Los_Angeles:20260914T130000
DTSTAMP:20260831T160054Z
CREATED:20260831T160054Z
LAST-MODIFIED:20260831T160054Z
UID:10001180-1789376400-1789390800@www.califesciences.org
SUMMARY:Thermo Fisher Mass Spec Symposium @ MBC Biolabs
DESCRIPTION:From Sample to Insight: Advancing Mass Spectrometry Workflow\nJoin us for a morning of mass spectrometry innovation\, practical workflows\, and emerging applications spanning sample preparation\, quantitative proteomics\, structural biology\, and biopharmaceutical research. \nHear from MS experts as they share practical approaches\, new technologies\, and advanced workflows designed to improve reproducibility\, quantitation\, and insights across biopharmaceutical research and drug discovery. \nAgenda:\n9:00am – 9:15am | Welcome & Opening Remarks \n9:15am – 9:45am | Yanan Yang\, Director of MS CenterMBC BioLabsMBC BioLabs Advanced MS Center Introduction \n9:45am – 10:15am | Jae Choi\, Ph.D.\, MBA\, Staff ScientistThermo Fisher ScientificAdvancing Mass Spectrometry Sample Preparation: Introducing New Solutions \n10:15am – 10:45am | Quoc Hoang\, Staff Scientist\, Sample PrepThermo Fisher ScientificSimplifying Mass Spectrometry Sample Preparation with the KingFisher Platform: High-Throughput Automation for Enhanced Reproducibility and Ease of Use \n10:45am – 11:00am | BREAKBreak & Networking \n11:00am – 11:30am | Jonathan Mcnally\, LCMS Technical Sales SpecialistThermo Fisher ScientificRecent Advancements in Mass Spectrometry for Biological Research \n11:30am – 12:00pm | Jae Choi\, Ph.D.\, MBA\, Staff ScientistThermo Fisher ScientificIntegrated HCP Enrichment and Heavy Peptides for Quantitative LC-MS of Critical HCPs \n12:00pm – 12:30pm | Weijing Liu\, Ph.D.\, Senior ManagerThermo Fisher ScientificStructural Biology Mass Spectrometry: Bridging Structure and Function in Drug Discovery \n12:30pm – 1:00pm | Lunch\, Networking & Meet the Experts \nCoffee\, snacks\, and Lunch will be provided \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/mass-spec-symposium-mbc-biolabs/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260806T120000
DTEND;TZID=America/Los_Angeles:20260806T130000
DTSTAMP:20260727T195002Z
CREATED:20260727T195002Z
LAST-MODIFIED:20260727T195002Z
UID:10001134-1786017600-1786021200@www.califesciences.org
SUMMARY:Withum Tax Lunch & Learn: Maximizing Tax Incentives for Growth-Stage Life Sciences Companies
DESCRIPTION:Join Withum’s tax specialists for an insightful Lunch & Learn focused on two of the most valuable tax incentives available to emerging and high-growth life sciences companies: Qualified Small Business Stock (QSBS) and the Research & Development (R&D) Tax Credit. \nWhether you’re developing groundbreaking technologies\, raising capital\, or planning for future liquidity events\, understanding these incentives can have a significant impact on your company’s growth strategy and long-term value. Learn how early-stage decisions around entity structure\, equity issuance\, and compliance can help preserve valuable QSBS benefits that may allow shareholders to exclude up to 100% of eligible capital gains. We’ll also explore how companies can leverage the R&D Tax Credit to offset federal tax liabilities—or even generate immediate cash flow benefits through payroll tax offsets of up to $500\,000 annually. \nDuring this interactive session\, you’ll gain practical insights into: \n\nMaximizing QSBS opportunities through proactive planning and structuring\nCommon pitfalls that can jeopardize valuable tax benefits\nIdentifying qualifying R&D activities and expenses\nMonetizing R&D credits even when operating at a loss\nTax strategies that help fuel innovation\, growth\, and investor value\n\nEnjoy lunch\, connect with fellow innovators and walk away with actionable strategies that could help your company reduce taxes\, improve cash flow and position itself for long-term success. \nWho Should Attend: Founders\, CEOs\, CFOs\, finance leaders\, investors and life sciences professionals interested in optimizing tax incentives and enhancing enterprise value. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/withum-tax-lunch-learn/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260805T170000
DTEND;TZID=America/Los_Angeles:20260805T203000
DTSTAMP:20260727T193721Z
CREATED:20260727T193721Z
LAST-MODIFIED:20260727T193721Z
UID:10001131-1785949200-1785961800@www.califesciences.org
SUMMARY:Sierra Nights
DESCRIPTION:The future of science is outsourcing. In this Sierra Nights\, we will explore how biotech startups can work effectively with CROs and CRDMOs\, from choosing the right partner to designing studies\, managing timelines\, interpreting data\, and avoiding common outsourcing mistakes. \n​A CRO\, or Contract Research Organization\, is an external company that provides specialized research services to biotech and pharmaceutical companies\, including assay development\, preclinical studies\, toxicology\, pharmacology\, formulation\, manufacturing support\, clinical trial operations\, and more. \n​The evening will include a panel of biotech leaders who have worked with CROs across different stages of company building and drug development. They will share practical lessons on what worked\, what went wrong\, how to communicate expectations\, and how to turn outsourced experiments into decision-ready data. \n​The event will also include participation from CRO sponsors\, giving founders a chance to meet service providers\, ask questions\, and better understand how to evaluate potential partners. \n​5:00 – 6:00pm: Doors Open and Networking\n​6:00 – 6:15: Host & Sponsors Introductions\n​6:15 – 7:30pm: Panel Discussions\n​7:30 – 9:00: Reception\, Music\, and Networking \nFounder and CRO Panelists:\n​Leah Makley\, PhD\, is Chief Operating Officer of MBC BioLabs\, the Bay Area’s largest life sciences incubator supporting 200+ biotech startups across five sites. She brings over a decade of firsthand experience managing CRO relationships as a startup founder or executive: she co-founded and led ViewPoint Therapeutics\, developing novel small molecule therapeutics in ophthalmology as a virtual\, venture-backed company with a small team of 16. She later served as COO of Deciduous Therapeutics\, and is now building Ocutheia\, a new ophthalmology company advancing a novel small molecule therapeutic on a primarily virtual basis. Across all three\, Leah has relied on CRO partners\, giving her a founder’s-eye view of what it takes to manage quality\, timelines\, and budget through those relationships. Leah holds a PhD in medicinal chemistry from the University of Michigan.\n​\n​Stephen Floor\, PhD\, is the Head of Biology at Marigold Bio where he uses AI and scalable experiments to advance genetic medicines. In his current role\, Stephen actively identifies\, contacts\, negotiates with\, evaluates\, and executes research plans with CROs spanning diverse research domains. He formerly led R&D and strategy work at Inceptive using generative AI to design mRNA therapeutics. Prior to Inceptive\, Stephen was a professor at the University of California\, San Francisco studying RNA regulation in human cells and how it is altered in cancers and developmental disorders. Stephen has deep experience managing distributed teams and CROs in academic and biotech environments\, including working across timezones and continents – and the challenges and opportunities that creates experimentally and logistically. Stephen received his PhD in Biophysics from UCSF.\n​\n​Debanu Das\, PhD\, is the Co-Founder and CEO of Accelero Biostructures and Co-Founder of XPose Therapeutics\, where he pioneered a structure-first approach to drugging traditionally “undruggable” targets\, using 3D crystal structures of small molecules bound to DNA Damage Response (DDR) proteins to generate novel therapeutic leads. This DDR-focused pipeline supports multiple treatment strategies\, including enzyme inhibition\, synthetic lethality\, and targeted-protein degradation. XPose’s discovery was powered by Accelero’s high-throughput protein X-ray crystallography platforms\, which enabled rapid fragment screening and iterative\, structure-guided optimization of hit compounds. In 2026\, XPose was acquired by Mid-Atlantic BioTherapeutics (MABT). Debanu joined MABT’s leadership team as part of the acquisition\, bringing over 20 years of expertise in structural biology\, drug discovery and outsourced R&D with CROs. Debanu holds a PhD from Rutgers-The State University of New Jersey\, New Brunswick\, and an Integrated MS from the Indian Institute of Technology\, Kanpur.\n​\n​Will DeLoache is co-founder and CEO of Tabulous\, a data platform for life sciences R&D teams. Previously\, he co-founded Novome Biotechnologies\, a South San Francisco company engineering bacterial therapeutics for chronic disease\, where he served as CEO and later CSO. During his tenure\, Novome advanced its programs from early-stage research through Phase 2 clinical trials and established a therapeutic partnership with Genentech\, working with CROs and CDMOs across preclinical\, manufacturing\, and clinical development. He holds a PhD in Bioengineering from UC Berkeley and a BS in Biology from Davidson College. \n​Sponsors: WuXi Biologics\, Transpharmation\, Clutch Bio \n​Who should apply\nPeople building or operating in biotech and related life science workflows. \n​About Sierra Nights\nSierra Nights is an event series for the parts of biotech that don’t show up on slides. The gaps people are dealing with\, the tools they’re actually using\, and the signals worth paying attention to. \n​About MBC BioLabs\nMBC BioLabs\, flexible lab-space for ambitious biotech companies tackling today’s biggest challenges. Learn more at www.mbcbiolabs.com \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/sierra-nights/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T170000
DTEND;TZID=America/Los_Angeles:20260624T193000
DTSTAMP:20260622T155437Z
CREATED:20260622T155437Z
LAST-MODIFIED:20260622T155437Z
UID:10001113-1782320400-1782329400@www.califesciences.org
SUMMARY:AI for Population Health
DESCRIPTION:Join Leah Makley\, MBC’s Chief Operating Officer and Lee Sanders\, MD\, MPH\, from Stanford University School of Medicine for “AI for Population Health: Nurturing Science for Longer\, Healthier Lives” \n​This conversation explores how artificial intelligence is reshaping population health by turning large-scale biological\, clinical\, environmental\, and behavioral data into actionable insights that can improve outcomes across entire communities. \n​Focusing on the theme of “nurturing science for everyone to live the longest\, healthiest life\,” we will discuss how modern AI methods\, ranging from predictive modeling to causal inference and multimodal data integration. are enabling earlier disease detection\, more precise risk stratification\, and more effective prevention strategies at scale. Special attention will be given to how these tools can be translated from research settings into real-world impact through biotech innovation\, healthcare partnerships\, and data infrastructure. For the MBC BioLabs community\, the session will highlight opportunities and challenges in building responsible\, scalable AI systems that not only advance scientific discovery but also meaningfully reduce health disparities and extend healthy lifespan across diverse populations. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/ai-for-population-health/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251113T153000
DTEND;TZID=America/Los_Angeles:20251113T193000
DTSTAMP:20251014T192249Z
CREATED:20251014T192249Z
LAST-MODIFIED:20251014T192249Z
UID:10000913-1763047800-1763062200@www.califesciences.org
SUMMARY:MBC BioLabs ClimateTech & AgTech Innovation Forum
DESCRIPTION:The MBC BioLabs ClimateTech & AgTech Innovation Forum on November 13th will bring together leading startups and investors for a focused evening of insight\, connection\, and opportunity. \nThis event will feature:\n🪴 Work at the forefront of sustainable manufacturing\, from proteins to biodegradable materials\n🌽 Products that use AI-powered genetics or microbe-based fertilizer to expand opportunities in agriculture\n🐄 Biotech solutions to improving feed efficiency while reducing methane production in cattle \nPresenting companies include Heritable Agriculture\, Ten Lives\, Switch Bioworks\, Ruby Bio\, Pasture Biosciences\, and Andean Systems. \nThis is an invitation-only event intended to build community between Climate and Ag Tech startups and the investors who support them. If this is you\, we’d love to see you there! \nREGISTER»
URL:https://www.califesciences.org/event/mbc-biolabs-climatetech-agtech-innovation-forum/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://www.califesciences.org/wp-content/uploads/2025/01/Industry-Event.jpg
END:VEVENT
END:VCALENDAR